Frontlight ResearchEarly access
Lung cancer trials in Japan
3 of 135 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in JapanReal-world Outcome of Zongertinib in Japan (J-HERZ)
- Where
- Tokyo
- Age
- 18 years and over
- People
- 300
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07926308 - No phaseTaking peopleSurvey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer
- Where
- Tokyo
- People
- 500
- Run by
- Takeda
See details and how to joinNCT05100069 - No phaseNot yet taking people in JapanA Prospective Study Investigating the Relationship Between Minimal Residual Disease Detection, Monitoring Frequency, and Prognosis in Non-small Cell Lung Cancer Patients Eligible for Curative Treatment.
- Where
- Chuo Ku
- Age
- 18 years and over
- People
- 350
- Run by
- National Cancer Center, Japan
See details and how to joinNCT06854939